Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Core EBITDA Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) 96.50-

What is the latest Core EBITDA Growth ratio of GENPHARMASEC ?

The latest Core EBITDA Growth ratio of GENPHARMASEC is 96.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202496.50
Mar2023-

How is Core EBITDA Growth of GENPHARMASEC Trending?

Years Core EBITDA Growth % Change
Mar2024 96.5
0
Mar2023 0 -

Other Financial Ratios of GENPHARMASEC


Compare Core EBITDA Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹125.1 Cr 6.1% -24.2% -45.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,956.1 Cr 1% -14.8% 45.9% Stock Analytics
KIRI INDUSTRIES ₹3,109.7 Cr 5.6% 1.4% 36.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,278.7 Cr 2.7% -9.9% 4.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,109.8 Cr 7.4% 27% 81.4% Stock Analytics
BODAL CHEMICALS ₹742.6 Cr -1.3% -4.5% -25.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

6.1%

-24.2%

-45.6%

SENSEX

-0.8%

-1.6%

3.1%


You may also like the below Video Courses